CTMX – cytomx therapeutics, inc. (US:NASDAQ)
Stock Stats
News
CytomX Therapeutics (NASDAQ:CTMX) had its price target raised by analysts at Cantor Fitzgerald from $6.00 to $10.00. They now have an "overweight" rating on the stock.
CytomX Therapeutics to Present at Upcoming February Conferences [Yahoo! Finance]
CytomX Therapeutics to Present at Upcoming February Conferences
CytomX Therapeutics (NASDAQ:CTMX) was given a new $10.00 price target on by analysts at Barclays PLC.
CytomX Therapeutics (CTMX) Is Up 14.0% After Early Probody Colorectal Cancer Data Are Welcomed By Analysts – Has The Bull Case Changed? [Yahoo! Finance]
Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: FMR LLC
Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Lester Rachael
Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Chu Yu-Waye
Form 4 CytomX Therapeutics, For: Feb 02 Filed by: BELVIN MARCIA
Form 4 CytomX Therapeutics, For: Feb 02 Filed by: Ogden Christopher
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.